Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Impinj Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Impinj Inc trades at $189.55 (market cap $5.60B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Impinj Inc are close in size by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Impinj Inc for 22 Days on average.
| IOVA | PI | |
|---|---|---|
Market Cap | $6.04B | $5.60B |
Volume | 14,805,993 | 9,929 |
Sector | Health | Technology |
52-Week High | $14.82 | $241.91 |
52-Week Low | $1.81 | $91.34 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $5.97B | $5.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Impinj (PI) trades at $189.55, down 0.78% for the day, with strong analyst support showing 16 buy ratings and a $178.83 consensus price target. The stock exhibits bullish technical signals with recent earnings beats in Q1 and Q2 2026, though the company remains unprofitable with negative net margins. Recent news highlights management presentations at investor conferences and upcoming Q3 earnings announcement.
The stock presents growth potential with revenue expansion and strong institutional interest, but faces fundamental challenges with negative profitability and elevated valuation multiples. Key risks include execution on profitability targets and competitive pressures in the RFID chip market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
